Sanofi Consumer Healthcare India Ltd.

4,070.8

15.1 (0.4%)

SANOFICONR Share Price
As on January 21, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap9,276 Cr
P/E Ratio51.73
Dividend Yield0.14 %
Trendline Performance

Unlock Stock of the Month

T&C*

Company Information


Market Insights
Open4,080
High4,100
NSE SymbolSANOFICONR
Close4,070.8
Low3,990
BSE Symbol544250
Previous Years High/Low
1 Year High5,894.5
3 Year High5,894.5
5 Year High5,894.5
1 Year Low3,990
3 Year Low3,990
5 Year Low3,990

Technicals


IndicatorsValueSignal
5-DMA4,107.76Bearish
10-DMA4,229.94Bearish
20-DMA4,361.81Bearish
50-DMA4,550.73Bearish
100-DMA4,731.19Bearish
200-DMA4,899.56Bearish

Historical Performance


1 Year
-15.8%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:-15.6
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 51.73, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -17.0%, indicating poor shareholder returns.
  • The stock carries a low beta of 0.1, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported an EBITDA of ₹2836 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹7245 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 843969
No. of Shares: 207 (Approx)
Performance:-15.6%
P/L: ₹-156031
NIFTY Performance: 8.6%
1 day Top Gainers
SymbolChange%
CREDITACC1355.2(9%)
MRPL152.16(9%)
KPRMILL859.05(6%)
INDIAMART2264.6(6%)
ETERNAL283.5(5%)
1 Day Top Losers
SymbolChange%
KALYANKJIL396.55(-12%)
SRF2676.9(-7%)
AIIL569.6(-7%)
TATACOMM1617.8(-6%)
TATACHEM693.8(-5%)
CYIENT1123.2(-5%)
GPPL169.3(-5%)
PAYTM1235.9(-5%)

Top Performing Stocks from the same sector


Mangalam Drugs And Organics Ltd.

105%

49.22

1 Month Performance

NGL Fine-Chem Ltd.

17.4%

1501

1 Month Performance

Ind-Swift Laboratories Ltd.

13.8%

106.28

1 Month Performance

Emcure Pharmaceuticals Ltd.

12.5%

1557.9

1 Month Performance

Aarti Pharmalabs Ltd.

6.3%

793.9

1 Month Performance

Torrent Pharmaceuticals Ltd.

4.8%

3981.8

1 Month Performance

JB Chemicals & Pharmaceuticals Ltd.

4.4%

1884.6

1 Month Performance

Kopran Ltd.

4.2%

135.35

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month